Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice

Gut Microbes

Volumn 6, Issue 1, 2015, Pages 10-23

  Aguilera, M ^a   Cerda Cuellar M ^b   Martínez, Vicente ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b IRTA   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Cannabinoid receptors; Colonic motility; Gut commensal microbiota; Innate immune system; Intestinal dysbiosis; Opioid receptors; Visceral sensitivity

Indexed keywords

ACETIC ACID; ANTIBIOTIC AGENT; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CAPSAICIN; CYTOKINE; MU OPIATE RECEPTOR; SECRETORY IMMUNOGLOBULIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC INDUCED DYSBIOSIS; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COUNT; BACTERIUM ADHERENCE; BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM; COLON FLORA; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DYSBIOSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GASTROINTESTINAL MOTILITY; HOST PATHOGEN INTERACTION; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INTESTINE CONTRACTION; INTESTINE LYMPHATIC TISSUE; LACTOBACILLUS; MOUSE; MYENTERIC PLEXUS; NONHUMAN; ORGANISMAL INTERACTION; PAIN RECEPTOR; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ANALYSIS; VISCERAL PAIN; ANIMAL; CHEMICALLY INDUCED; COLON; DRUG EFFECTS; INTESTINE FLORA; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); BACTEROIDES; BIFIDOBACTERIUM; CLOSTRIDIUM COCCOIDES; MUS;

ANIMALS; ANTI-BACTERIAL AGENTS; COLON; DYSBIOSIS; FEMALE; GASTROINTESTINAL MICROBIOME; MICE;

EID: 84924246933     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.4161/19490976.2014.990790     Document Type: Article

References (66)

1. Sood R, Law GR, Ford AC. Diagnosis of IBS: symptoms, symptom-based criteria, biomarkers or "psychomarkers"? Nat Rev Gastroenterol Hepatol 20l4; 11(11):683-91; http://dx.doi.org/10.1038/nrgastro.2014.127.
2. Simren M. IBS with intestinal microbial dysbiosis: a new and clinically relevant subgroup? Gut 2014; 63:1685-6; PMID:24569059; http://dx.doi.org/10.1136/gutjnl-2013-306434.
3. Lee YJ, Park KS. Irritable bowel syndrome: emerging paradigm in pathophysiology. World J Gastroenterol 2014; 20:2456-69; PMID:24627583; http://dx.doi.org/10.3748/wjg.v20.i10.2456.
4. Ishihara S, Tada Y, Fukuba N, Oka A, Kusunoki R, Mishima Y, Oshima N, Moriyama I, Yuki T, Kawa-shima K, et al. Pathogenesis of irritable bowel syndrome-review regarding associated infection and immune activation. Digestion 2013; 87:204-11;PMID:23712295; http://dx.doi.org/10.1159/000350054.
5. O'Hara AM, Shanahan F. The gut flora as a forgotten organ. EMBO Rep 2006; 7:688-93; PMID:16819463; http://dx.doi.org/10.1038/sj.embor.7400731.
6. Cerf-Bensussan N, Gaboriau-Routhiau V. The immune system and the gut microbiota: friends or foes? Nat Rev Immunol 2010; 10:735-44; PMID:20865020; http://dx.doi.org/10.1038/nri2850.
7. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol 2008; 8:411-20; PMID:18469830; http://dx.doi.org/10.1038/nri2316.
8. Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology 2009; 136:2003-14; PMID:19457424; http://dx.doi.org/10.1053/j.gastro.2009.01.075.
9. De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: stressed bugs, stressed brain or both? J Physiol 2014; 592:2989-97; PMID:24756641; http://dx.doi.org/10.1113/jphysiol.2014.273995.
10. Koboziev I, Reinoso Webb C, Furr KL, Grisham MB. Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med 2014; 68:12233; PMID:24275541; http://dx.doi.org/10.1016/j.freeradbiomed.2013.11.008.
11. Duerkop BA, Vaishnava S, Hooper L V. Immune responses to the microbiota at the intestinal mucosal surface. Immunity 2009; 31:368-76; PMID:19766080; http://dx.doi.org/10.1016/j.immuni.2009.08.009.
12. Kamada N, Chen GY, Inohara N, Nunez G. Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 2013; 14:685-90; PMID:23778796; http://dx.doi.org/10.1038/ni.2608.
13. Foxx-Orenstein AE, Chey WD. Manipulation of the Gut Microbiota as a Novel Treatment Strategy for Gastrointestinal Disorders. Am J Gastroenterol Suppl 2012; 1:41-6..
14. Jalanka-Tuovinen J, Saloj arvi J, Salonen A, Immonen O, Garsed K, Kelly FM, Zaitoun A, Palva A, Spiller RC, de Vos WM. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 2013; 63:1737-45; PMID:24310267; http://dx.doi.org/10.1136/gutjnl-2013-305994.
15. Simren M, Barbara G, Flint HJ, Spiegel BMR, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013; 62:159-76; PMID:22730468; http://dx.doi.org/10.1136/gutjnl-2012-302167.
16. Soderholm JD, Yang P-C, Ceponis P, Vohra A, Riddell R, Sherman PM, Perdue MH. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology 2002; 123:1099-108; PMID:12360472; http://dx.doi.org/10.1053/gast.2002.36019.
17. Verdu EF, Collins SM. Irritable bowel syndrome and probiotics: from rationale to clinical use. Curr Opin Gastroenterol 2005; 21:697-701; PMID:16220048; http://dx.doi.org/10.1097/01.mog.0000182861.11669.4d.
18. Verdu EF, Bercik P, Verma-Gandhu M, Huang X-X, Blennerhassett P, Jackson W, Mao Y, Wang L, Rochat F, Collins SM. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut2006; 55:182-90; PMID:16105890;http://dx.doi.org/10.1136/gut.2005.066100.
19. Aguilera M, Vergara P, Martínez V. Stress and antibiotics alter luminal and wall-adhered microbiota and enhance the local expression of visceral sensory-related systems in mice. Neurogastroenterol Motil 2013; 25: e515-29; PMID:23711047; http://dx.doi.org/10.1111/nmo.12154.
20. Barbara G, Stanghellini V, Brandi G, Cremon C, Di Nardo G, De Giorgio R, Corinaldesi R. Interactions between commensal bacteria and gut sensorimotor function in health and disease. Am J Gastroenterol 2005; 100:2560-8; PMID:16279914; http://dx.doi.org/10.1111/j.1572-0241.2005.00230.x.
21. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy L, Dubuquoy C, Merour E, Geboes K, Chamaillard M, et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabi-noid receptors. Nat Med 2007; 13:35-7;PMID:17159985; http://dx.doi.org/10.1038/nm1521.
22. Collins S, Verdu E, Denou E, Bercik P. The role of pathogenic microbes and commensal bacteria in irritable bowel syndrome. Dig Dis 2009; 27(Suppl 1):85-9;PMID:20203502; http://dx.doi.org/10.1159/000268126.
23. Goto Y, Ivanov II. Intestinal epithelial cells as mediators of the commensal-host immune crosstalk. Immunol Cell Biol 2013; 91:204-14; PMID:23318659; http://dx.doi.org/10.1038/icb.2012.80.
24. Salzman NH, Bevins CL. Dysbiosis—A consequence of Paneth cell dysfunction. Semin Immunol 2013; 25:334-41; PMID:24239045; http://dx.doi.org/10.1016/j.smim.2013.09.006.
25. Saulnier DM, Ringel Y, Heyman MB, Foster JA, Ber-cik P, Shulman RJ, Versalovic J, Verdu EF, Dinan TG, Hecht G, et al. The intestinal microbiome, probiotics and prebiotics in neurogastroenterology. Gut Microbes 2013; 4:17-27; PMID:23202796; http://dx.doi.org/10.4161/gmic.22973.
26. Wlodarska M, Willing B, Keeney KM, Menendez A, Bergstrom KS, Gill N, Russell SL, Vallance BA, Finlay BB. Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated Citrobacter rodentium-induced colitis. Infect Immun 2011; 79:1536-45; PMID:21321077; http://dx.doi.org/10.1128/IAI.01104-10.
27. Domínguez PM, Ardavín C. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol Rev 2010; 234:90-104; PMID:20193014; http://dx.doi.org/10.1111/j.0105-2896.2009.00876.x.
28. Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ, Bushman FD, Artis D. Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 2010; 3:148-58; PMID:19940845; http://dx.doi.org/10.1038/mi.2009.132.
29. Puhl NJ, Uwiera RRE, Yanke LJ, Selinger LB, Inglis GD. Antibiotics conspicuously affect community profiles and richness, but not the density of bacterial cells associated with mucosa in the large and small intestines of mice. Anaerobe 2012; 18:67-75; PMID:22185696; http://dx.doi.org/10.1016/j.anaerobe.2011.12.007.
30. Croswell A, Amir E, Teggatz P, Barman M, Salzman NH. Prolonged impact of antibiotics on intestinal microbial ecology and susceptibility to enteric Salmonella infection. Infect Immun 2009; 77:2741-53;PMID:19380465; http://dx.doi.org/10.1128/IAI.00006-09.
31. Dinan TG, Cryan JF. Regulation of the stress response by the gut microbiota: implications for psychoneuroen-docrinology. Psychoneuroendocrinology 2012; 37:1369-78.; PMID:22483040; http://dx.doi.org/10.1016/j.psyneuen.2012.03.007.
32. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R A role for inflammation in irritable bowel syndrome? Gut 2002; 51(Suppl 1):i41-4; PMID:12077063; http://dx.doi.org/10.1136/gut.51.suppl_1.i41.
33. Xu D, Gao J, Gillilland M, Wu X, Song I, Kao JY, Owyang C. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology 2014; 146:484-96.e4; PMID:24161699; http://dx.doi.org/10.1053/j.gastro.2013.10.026.
34. Barnes MJ, Powrie F. Immunology. the gut's clostridium cocktail. Science 2011; 331:289-90; PMID:21252334; http://dx.doi.org/10.1126/science.1201291.
35. Koboziev I, Reinoso Webb C, Furr KL, Grisham MB. Role of the enteric microbiota in intestinal homeostasis and inflammation. Free Radic Biol Med 2013; 68C:122-33..
36. Swidsinski A, Loening-Baucke V, Lochs H, Hale L-P. Spatial organization of bacterial flora in normal and inflamed intestine: a fluorescence in situ hybridization study in mice. World J Gastroenterol 2005; 11:113140; PMID:15754393; http://dx.doi.org/10.3748/wjg.v11.i8.1131.
37. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010; 10:131-44;PMID:20098461; http://dx.doi.org/10.1038/nri2707.
38. Teran-Ventura E, Aguilera M, Vergara P, Martinez V. Specific changes of gut commensal microbiota and TLRs during indomethacin-induced acute intestinal inflammation in rats. J Crohns Colitis 2014; 8:104354; PMID:24566169; http://dx.doi.org/10.1016/j.crohns.2014.02.001.
39. Terian-Ventura E, Roca M, Martin MT, Abarca ML, Martinez V, Vergara P. Characterization of housing-related spontaneous variations of gut microbiota and expression of toll-like receptors 2 and 4 in rats. Microb Ecol 2010; 60:691-702; PMID:20717659; http://dx.doi.org/10.1007/s00248-010-9737-z.
40. Reikvam DH, Erofeev A, Sandvik A, Grcic V, Jahnsen FL, Gaustad P, McCoy KD, Macpherson AJ, Meza-Zepeda LA, Johansen F-E. Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression. PLoS One 2011; 6:e17996; PMID:21445311.
41. Deplancke B, Gaskins HR. Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am J Clin Nutr 2001; 73:1131S-41S;PMID:11393191.
42. Boue J, Basso L, Cenac N, Blanpied C, Rolli-Derkinde-ren M, Neunlist M, Vergnolle N, Dietrich G. Endogenous regulation of visceral pain via production of opioids by colitogenic CD4(C) T cells in mice. Gastroenterology 2014; 146:166-75; PMID:24055279; http://dx.doi.org/10.1053/j.gastro.2013.09.020.
43. Distrutti E, Cipriani S, Mencarelli A, Renga B, Fior-ucci S. Probiotics VSL#3 protect against development of visceral pain in murine model of irritable bowel syndrome. PLoS One 2013; 8:e63893; PMID:23691109.
44. Brusberg M, Arvidsson S, Kang D, Larsson H, Lindstrom E, Martinez V. CB1 receptors mediate the analgesic effects of cannabinoids on colorectal distension-induced visceral pain in rodents. J Neurosci 2009; 29:1554-64; PMID:19193902; http://dx.doi.org/10.1523/JNEUROSCI.5166-08.2009.
45. Wright KL, Duncan M, Sharkey KA. Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. Br J Pharmacol 2008; 153:263-70; PMID:17906675; http://dx.doi.org/10.1038/sj.bjp.0707486.
46. Jardi F, Fernandez-Blanco JA, Martinez V, Vergara P. Plasticityofdorsal root ganglion neurons in a ratmodel of post-infectious gut dysfunction: potential implication of nerve growth factor. Scand J Gastroenterol 2014; 49:1296-303; PMID:25259719; http://dx.doi.org/10.3109/00365521.2014.958524.
47. Meseguer V, Alpizar YA, Luis E, Tajada S, Denlinger B, Fajardo O, Manenschijn J-A, Fernaindez-Pena C, Talavera A, Kichko T, et al. TRPA1 channels mediate acute neurogenic inflammation and pain produced by bacterial endotoxins. Nat Commun 2014; 5:3125; PMID:24445575; http://dx.doi.org/10.1038/ncomms4125.
48. Tramullas M, Finger BC, Moloney RD, Golubeva AV, Moloney G, Dinan TG, Cryan JF. Toll-like receptor 4 regulates chronic stress-induced visceral pain in mice. Biol Psychiatry 2014; 76:340-8; PMID:24331544; http://dx.doi.org/10.1016/j.biopsych.2013.11.004.
49. Cash BD. Emerging role ofprobiotics and antimicrobials in the management of irritable bowel syndrome. Curr Med Res Opin 2014; 30:1405-15; PMID:24666019; http://dx.doi.org/10.1185/03007995.2014.908278.
50. Guglielmetti S, Mora D, Gschwender M, Popp K. Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life—a double-blind, placebo-controlled study. Aliment Pharmacol Ther 2011; 33:1123-32; PMID:21418261; http://dx.doi.org/10.1111/j.1365-2036.2011.04633.x.
51. Koo HL, DuPont HL. Rifaximin: auniquegastrointes-tinal-selective antibiotic for enteric diseases. Curr Opin Gastroenterol 2010; 26:17-25; PMID:19881343; http://dx.doi.org/10.1097/MOG.0b013e328333dc8d.
52. Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95:3503-6; PMID:11151884; http://dx.doi.org/10.1111/j.1572-0241.2000.03368.x.
53. Anitha M, Vijay-Kumar M, Sitaraman S V, Gewirtz AT, Srinivasan S. Gut microbial products regulate murine gastrointestinal motility via Toll-like receptor 4 signaling. Gastroenterology 2012; 143:1006-16.e4;PMID:22732731; http://dx.doi.org/10.1053/j.gastro.2012.06.034.
54. Bär F, Von Koschitzky H, Roblick U, Bruch HP, Schulze L, Sonnenborn U, Bottner M, Wedel T. Cellfree supernatants of Escherichia coli Nissle 1917 modulate human colonic motility: evidence from an in vitro organ bath study. Neurogastroenterol Motil 2009; 21:559-66, e16—7; PMID:19220758; http://dx.doi.org/10.1111/j.1365-2982.2008.01258.x.
55. Guyonnet D, Chassany O, Ducrotte P, Picard C, Mouret M, Mercier C-H, Matuchansky C. Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: a multicentre, randomized, double-blind, controlled trial. Aliment Pharmacol Ther 2007; 26:475-86; PMID:17635382; http://dx.doi.org/10.1111/j.1365-2036.2007.03362.x.
56. Quigley EMM. Bacteria: a new player in gastrointestinal motility disorders—infections, bacterial overgrowth, and probiotics. Gastroenterol Clin North Am 2007; 36:735-48, xi; PMID:17950446; http://dx.doi.org/10.1016/j.gtc.2007.07.012.
57. Van der Waaij D, Berghuis-de Vries JM, Korthals Altes C. Oral dose and faecal concentration of antibiotics during antibiotic decontamination in mice and in a patient. J Hyg (Lond) 1974; 73:197-203; PMID:4528886.
58. Aguilera M, Vergara P, Martínez V. Environment-related adaptive changes of gut commensal microbiota do not alter colonic toll-like receptors but modulate the local expression of sensory-related systems in rats. Microb Ecol 2013; 66:232-43; PMID:23666270; http://dx.doi.org/10.1007/s00248-013-0241-0.
59. Furet J-P, Firmesse O, Gourmelon M, Bridonneau C, Tap J, Mondot S, Doríe J, Corthier G. Comparative assessment of human and farm animal faecal micro-biota using real-time quantitative PCR. FEMS Microbiol Ecol 2009; 68:351-62; PMID:19302550; http://dx.doi.org/10.1111/j.1574-6941.2009.00671.x.
60. Zwielehner J, Lassl C, Hippe B, Pointner A, Switzeny OJ, Remely M, Kitzweger E, Ruckser R, Haslberger AG. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One 2011; 6: e28654; PMID:22194876.
61. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25:402-8..
62. Martínez V, Thakur S, Mogil JS, Tache Y, Mayer EA. Differential effects of chemical and mechanical colonic irritation on behavioral pain response to intraperitoneal acetic acid in mice. Pain 1999; 81:179-86;PMID:10353506; http://dx.doi.org/10.1016/S0304-3959(99)00008-1.
63. Harmsen HJM, Raangs GC, He T, Degener JE, Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002; 68:2982-90; PMID:12039758; http://dx.doi.org/10.1128/AEM.68.6.2982-2990.2002.
64. Haarman M, Knol J. Quantitative real-time PCR analysis of fecal Lactobacillus species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 2006; 72:2359-65; PMID:16597930; http://dx.doi.org/10.1128/AEM.72.4.2359-2365.2006.
65. Salzman NH, de Jong H, Paterson Y, Harmsen HJM, Welling GW, Bos NA. Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria. Microbiology 2002; 148:3651-60;PMID:12427955.
66. Salzman NH, Hung K, Haribhai D, Chu H, Karlsson-Sjoberg J, Amir E, Teggatz P, Barman M, Hayward M, Eastwood D, et al. Enteric defensins are essential regulators of intestinal microbial ecology. Nat Immunol 2010; 11:76-83; PMID:19855381; http://dx.doi.org/10.1038/ni.1825.